Cargando…
ICD Shock, Not Ventricular Fibrillation, Causes Elevation of High Sensitive Troponin T after Defibrillation Threshold Testing—The Prospective, Randomized, Multicentre TropShock-Trial
BACKGROUND: The placement of an implantable cardioverter defibrillator (ICD) has become routine practice to protect high risk patients from sudden cardiac death. However, implantation-related myocardial micro-damage and its relation to different implantation strategies are poorly characterized. METH...
Autores principales: | Semmler, Verena, Biermann, Jürgen, Haller, Bernhard, Jilek, Clemens, Sarafoff, Nikolaus, Lennerz, Carsten, Vrazic, Hrvoje, Zrenner, Bernhard, Asbach, Stefan, Kolb, Christof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514854/ https://www.ncbi.nlm.nih.gov/pubmed/26208329 http://dx.doi.org/10.1371/journal.pone.0131570 |
Ejemplares similares
-
Biomarker-based diagnosis of pacemaker and implantable cardioverter defibrillator pocket infections: A prospective, multicentre, case-control evaluation
por: Lennerz, Carsten, et al.
Publicado: (2017) -
Frequent Home Monitoring of ICD Is Effective to Prevent Inappropriate Defibrillator Shock Delivery
por: Bifulco, Paolo, et al.
Publicado: (2014) -
Are ICD recipients able to foresee if they want to withdraw therapy or deactivate defibrillator shocks?()
por: Thylén, Ingela, et al.
Publicado: (2013) -
Relation between detection rate and inappropriate shocks in single versus dual chamber cardioverter-defibrillator – an analysis from the OPTION trial
por: Kolb, Christof, et al.
Publicado: (2016) -
Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial
por: Bänsch, Dietmar, et al.
Publicado: (2015)